| 秦闫威,袁宇翔,王勇,李艳,李均彪,陈节,许伟.经颈内静脉植入输液港:导管尖端处于不同位置时1年内并发症发生率与导管通畅率[J].中国介入影像与治疗学,2024,21(5):268-271 |
| 经颈内静脉植入输液港:导管尖端处于不同位置时1年内并发症发生率与导管通畅率 |
| Incidence of complications and catheter patency rate between different locations of catheter tip of venous access ports implanted through internal jugular vein within 1 year |
| 投稿时间：2024-01-24 修订日期：2024-04-16 |
| DOI：10.13929/j.issn.1672-8475.2024.05.003 |
| 中文关键词: 导管插入术，中心静脉 颈静脉 腔静脉，上 心房 |
| 英文关键词:catheterization, central venous jugular veins vena cava, superior heart atria |
| 基金项目: |
|
| 摘要点击次数: 218 |
| 全文下载次数: 212 |
| 中文摘要: |
| 目的 对比观察经颈内静脉（IJV）入路植入完全植入式静脉输液港（TIVAP）后，导管尖端处于不同位置时1年内并发症发生率及导管通畅率。方法 回顾性分析2 104例接受经IJV入路植入TIVAP的肿瘤患者，将接受经右IJV入路者（R组，n=1 903）分为导管尖端位于右心房上部［即上腔静脉（SVC）与右心房交界（CAJ）下方0.5～1.0 cm亚组（R1亚组，n=376）］与位于SVC下1/3至CAJ间亚组（R2亚组，n=1 527），将接受经左IJV入路者（L组，n=201）相应分为L1亚组（n=64）及L2亚组（n=137）；记录2组内各亚组患者基本资料、植入TIVAP 1年内并发症发生率及导管通畅率，并进行亚组间比较。结果 2组内亚组间患者性别、年龄、临床诊断及肿瘤分期，以及气胸/血气胸、局部皮肤损伤、TIVAP感染、导管相关性血栓、药物外渗、导管移位及心律失常等并发症发生率差异均无统计学意义（P均＞0.05）。R1（94.15%）与R2亚组（93.78%）（χ2=0.069，P=0.793）、L1（98.44%）与L2亚组（89.78%）1年内导管通畅率差异均无统计学意义（Yates连续性校正χ2=3.563，P=0.059）。结论 经左或右IJV入路植入TIVAP后，导管尖端位于右心房上部与SVC下1/3与CAJ之间时，1年内并发症发生率及导管通畅率均无明显差异。 |
| 英文摘要: |
| Objective To comparatively observe the incidence of complications and patency rate within 1 year after implantation of totally implantable venous access port (TIVAP) through internal jugular vein (IJV) between different locations of catheter tip. Methods Data of 2 104 patients with tumors who received TIVAP implantation through IJV were retrospectively analyzed. Patients who underwent TIVAP implantation through the right IJV (group R, n=1 903) were divided into R1 (n=376, with catheter tip located at the upper right atrium, i.e. 0.5 to 1.0 cm below the cavoatrial junction[CAJ]) and R2 subgroups (n=1 527, with catheter tips located between the lower 1/3 of superior vena cava[SVC] and CAJ), while those who underwent TIVAP implantation through the left IJV (group L, n=201) were divided into L1 (n=64) and L2 subgroups (n=137), respectively. Patients' basic information, incidence of complication and patency rate of catheter 1 year after TIVAP implantation were collected and compared between subgroups. Results No significant difference of gender, age, clinical diagnosis, tumor stage, nor of incidence of complication including pneumothorax/hemopneumothorax, local skin injury, TIVAP infection, catheter-associated thrombosis, drug extravasation, catheter displacement and arrhythmia was found between subgroups within group R nor L (all P>0.05). One year after TIVAP implantation, no significant difference of catheter patency rates was found between subgroup R1 (94.15%) and R2 (93.78%) (χ2=0.069, P=0.793), nor between subgroup L1 (98.44%) and L2 (89.78%) (Yates' continuity correction χ2=3.563, P=0.059). Conclusion No significant difference of incidence of complications nor catheter patency rate within 1 year after implantation of TIVAP was found between catheter tip location at the upper right atrium or between the lower 1/3 of SVC and CAJ through the right or left IJC. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
